| Date Checked | 2025-12-21 23:40:41 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | LYEL |
| AssetType | Common Stock |
| Name | Lyell Immunopharma Inc |
| Description | Lyell Immunopharma, Inc. is an innovative biopharmaceutical company based in South San Francisco, California, with additional facilities in Seattle and Bothell, Washington. The company is at the forefront of T-cell reprogramming technologies, focusing on creating advanced therapies targeting solid tumors to improve the effectiveness and durability of T-cell treatments. With its proprietary technology platforms and a mission to address substantial unmet needs in oncology, Lyell Immunopharma is strategically positioned to lead advancements in the immuno-oncology landscape, potentially revolutionizing cancer care. |
| CIK | 1806952 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080 |
| OfficialSite | https://www.lyell.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 708061000 |
| EBITDA | -184380992 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 17.06 |
| DividendPerShare | None |
| EPS | -22.75 |
| RevenuePerShareTTM | 0.003 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -2483.53 |
| ReturnOnAssetsTTM | -0.242 |
| ReturnOnEquityTTM | -0.757 |
| RevenueTTM | 41000 |
| GrossProfitTTM | 41000 |
| DilutedEPSTTM | -22.75 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.559 |
| AnalystTargetPrice | 29.67 |
| AnalystRatingStrongBuy | 0 |
| AnalystRatingBuy | 1 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 1 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 17269.78 |
| PriceToBookRatio | 2.144 |
| EVToRevenue | 10492.02 |
| EVToEBITDA | 0.251 |
| Beta | -0.11 |
| 52WeekHigh | 35.16 |
| 52WeekLow | 7.65 |
| 50DayMovingAverage | 20.97 |
| 200DayMovingAverage | 13.31 |
| SharesOutstanding | 21244000 |
| SharesFloat | 12171000 |
| PercentInsiders | 27.677 |
| PercentInstitutions | 50.164 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:40:41 |
| fresh | 1 |